...
首页> 外文期刊>Journal of clinical nursing >Assessment of body fluid status in hemodialysis patients using the body composition monitor measurement technique
【24h】

Assessment of body fluid status in hemodialysis patients using the body composition monitor measurement technique

机译:使用人体成分监测仪测量技术评估血液透析患者的体液状况

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims and objectives. The main objective of the study was to correlate the target dry weight in haemodialysis (HD) patients as assessed clinically by nephrologists to those measured by the Body Composition Monitor (BCM - Fresenius) machine. The second objective was to compare pre and postdialysis changes of extracellular fluid and clinical parameters. Background. Clinical assessment of target dry weight in HD patients remains problematic. Inaccurate dry weight resulted in hypovolaemic or overhydration states. The BCM (Fresenius) utilises bioimpedance technology for body fluid monitoring and has been extensively validated. Design. This was a prospective cross-sectional study on consecutive patients who underwent HD and gave informed consent. Methods. The target dry weights of these patients were first assessed by their attending nephrologists and appropriate ultrafiltration prescribed. Their body fluid statuses were then measured with the BCM before and after HD treatment. Results. Eighty HD patients (37 men, 43 women) with a mean age of 55±13years and a mean duration on HD of 71±56months were studied. The dry weight measured by BCM significantly correlated with dry weight assessed by the nephrologists. The mean dry weight was higher when assessed by the nephrologists compared to that by BCM. Only systolic blood pressure and not other components of blood pressure reduced after HD treatments. Conclusion. The BCM is a rapid and easy-to-use tool that can help HD nursing staffs to adjust patients' dry weights between nephrologists' reviews thus optimising HD therapy and patient outcomes. Relevance to clinical practice. We propose that experienced HD nursing staff be trained in the use of the BCM or other simple bioimpedance machines to help monitor patient overhydration and approximate dry weight in consultation with the nephrologists responsible for the care of these patients so as to obviate excessive residual overhydration between nephrology reviews.
机译:目的和目标。这项研究的主要目的是将肾病学家临床评估的血液透析(HD)患者的目标干重与身体成分监测仪(BCM-Fresenius)机所测量的目标干重相关联。第二个目的是比较透析前后细胞外液和临床参数的变化。背景。 HD患者目标干重的临床评估仍然存在问题。干重不正确会导致血容量不足或水合过剩。 BCM(Fresenius)利用生物阻抗技术进行体液监测,并已得到广泛验证。设计。这是一项对连续接受HD并获得知情同意的患者进行的前瞻性横断面研究。方法。这些患者的目标干重首先由其主治肾脏科医生评估,并开具适当的超滤法。然后在HD治疗之前和之后用BCM测量他们的体液状态。结果。研究对象为80名HD患者(37名男性,43名女性),平均年龄为55±13岁,HD平均持续时间为71±56个月。 BCM测量的干重与肾脏科医生评估的干重显着相关。肾脏科医生评估的平均干重高于BCM。 HD治疗后仅收缩压降低,而血压的其他成分未降低。结论。 BCM是一种快速且易于使用的工具,可以帮助HD护理人员在肾脏科医生的评论之间调整患者的干重,从而优化HD治疗和患者预后。与临床实践有关。我们建议对有经验的高清护理人员进行BCM或其他简单的生物阻抗机器使用方面的培训,以帮助监测患者的水合作用和近似干重,并与负责照顾这些患者的肾脏病专家进行协商,以消除肾脏科之间的过度残留水合作用评论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号